| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99232 |
Subsequent hospital care, per day, moderate complexity |
8,928 |
6,061 |
$183K |
| 99233 |
Prolong inpt eval add15 m |
3,864 |
2,819 |
$105K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,545 |
1,948 |
$28K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,936 |
1,427 |
$22K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
7,010 |
1,966 |
$13K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,038 |
1,920 |
$5K |
| 97116 |
|
2,348 |
795 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
157 |
61 |
$2K |
| 97162 |
|
449 |
446 |
$1K |
| G0316 |
Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes) |
102 |
87 |
$839.31 |
| 99223 |
Prolong inpt eval add15 m |
12 |
12 |
$520.08 |
| 97535 |
Self-care/home management training, each 15 minutes |
313 |
139 |
$229.55 |
| 97161 |
|
171 |
167 |
$133.10 |
| 85610 |
|
2,005 |
556 |
$0.00 |
| 92610 |
|
225 |
225 |
$0.00 |
| 84439 |
|
1,224 |
1,192 |
$0.00 |
| 80061 |
Lipid panel |
919 |
909 |
$0.00 |
| 87631 |
|
430 |
388 |
$0.00 |
| 90662 |
|
675 |
672 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
269 |
232 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
446 |
414 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
122 |
97 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
53 |
48 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
99 |
89 |
$0.00 |
| 0013A |
|
305 |
305 |
$0.00 |
| 84145 |
|
267 |
206 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
144 |
138 |
$0.00 |
| 0003A |
|
38 |
38 |
$0.00 |
| 90670 |
|
193 |
191 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
157 |
78 |
$0.00 |
| 91322 |
|
234 |
233 |
$0.00 |
| 91300 |
|
31 |
31 |
$0.00 |
| 84100 |
|
40 |
12 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
27 |
26 |
$0.00 |
| 82310 |
|
18 |
15 |
$0.00 |
| 83880 |
|
80 |
66 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
3,565 |
2,992 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,460 |
5,445 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
25,875 |
10,918 |
$0.00 |
| 85027 |
|
8,746 |
4,852 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
141 |
106 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
384 |
381 |
$0.00 |
| 81001 |
|
1,383 |
1,283 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
662 |
583 |
$0.00 |
| 51798 |
|
1,574 |
559 |
$0.00 |
| 82607 |
|
1,138 |
1,127 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
933 |
851 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,766 |
2,691 |
$0.00 |
| 83615 |
|
3,254 |
2,745 |
$0.00 |
| 82962 |
|
82,769 |
6,361 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
225 |
219 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,040 |
3,718 |
$0.00 |
| 97165 |
|
64 |
63 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,976 |
2,246 |
$0.00 |
| 86140 |
|
152 |
106 |
$0.00 |
| 83550 |
|
541 |
499 |
$0.00 |
| 0011A |
|
190 |
188 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
13 |
$0.00 |
| 0012A |
|
178 |
178 |
$0.00 |
| 90674 |
|
703 |
702 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
12 |
12 |
$0.00 |
| 82728 |
|
273 |
255 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
1,407 |
1,403 |
$0.00 |
| 92526 |
|
224 |
67 |
$0.00 |
| 83735 |
|
35 |
28 |
$0.00 |
| 90480 |
|
234 |
233 |
$0.00 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
45 |
43 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
193 |
191 |
$0.00 |
| 91301 |
|
112 |
112 |
$0.00 |
| 93288 |
|
12 |
12 |
$0.00 |